It's no different from a biotech play although there is much more M&A activity in the agchem sector for promising compounds like ours which shortens the lifespan as investors.
Partnering will be the key and many global biotechs have market caps in the hundreds of millions with strategic partnerships in late stage trials. It will take many solutions to overcome the long term issue of insecticide resistance in all verticals.
The next step for Bio-gene is taking time for good reason, as @Lefevre mentioned it's important to secure the right deal rather than any deal, especially after the Virbac withdrawal. Getting options in the money is a secondary target.
That being said it looks close, their website has been updated with greater detail and a new "Partners" section
The year as a whole has been incredibly productive for the company which has made real inroads in efficacy, toxicology and manufacturing from world class institutions including Purdue, CSIRO, Eurofins with the foundations built. Hence the opportunity.
- Forums
- ASX - By Stock
- News and media
It's no different from a biotech play although there is much...
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.001(2.33%) |
Mkt cap ! $8.859M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.4¢ | $5 | 112 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 12375 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8563 | 0.044 |
1 | 100000 | 0.039 |
1 | 118000 | 0.038 |
1 | 120050 | 0.037 |
1 | 64000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 30000 | 1 |
0.053 | 11511 | 1 |
0.054 | 59999 | 2 |
0.055 | 118498 | 1 |
0.061 | 225000 | 2 |
Last trade - 10.00am 29/11/2024 (20 minute delay) ? |
BGT (ASX) Chart |